Tevogen Bio Holdings Inc (NASDAQ:TVGN) shares traded -1.64% lower at $1.20 on Wall Street last session.
TVGN stock price is now 5.15% away from the 50-day moving average and 2.61% away from the 200-day moving average. The market capitalization of the company currently stands at $220.67M.
With the price target of $10, D. Boral Capital recently initiated with Buy rating for Tevogen Bio Holdings Inc (NASDAQ: TVGN).
In other news, Saadi Ryan H., Chief Executive Officer sold 1,438,206 shares of the company’s stock on Jun 09 ’25. The stock was sold for $1,768,993 at an average price of $1.23. Upon completion of the transaction, the Chief Executive Officer now directly owns 116,814,453 shares in the company, valued at $140.18 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 09 ’25, Officer Saadi Ryan H. bought 1,438,206 shares of the business’s stock. A total of $1,582,027 was incurred on buying the stock at an average price of $1.10. A total of 76.98% of the company’s stock is owned by insiders.
During the past 12 months, Tevogen Bio Holdings Inc has had a low of $0.26 and a high of $3.09. The fifty day moving average price for TVGN is $1.14116 and a two-hundred day moving average price translates $1.16953 for the stock.
The latest earnings results from Tevogen Bio Holdings Inc (NASDAQ: TVGN) was released for 2025-03-31.
